analytics in pharmaceutical industry

15
PHARMACEUTICALS PADMAKAR GUNTUR VAMSIDHAR M KRISHNA MUTTOJU PANKURI JAIN SWATI BAJAJ HIMA BINDHU

Upload: international-school-of-engineering

Post on 26-Jan-2015

130 views

Category:

Documents


4 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Analytics in Pharmaceutical Industry

PHARMACEUTICALS

PADMAKAR GUNTUR VAMSIDHAR M

KRISHNA MUTTOJUPANKURI JAINSWATI BAJAJ

HIMA BINDHU

Page 2: Analytics in Pharmaceutical Industry

InsightsWithin R&D there is need of superior innovation and

lower costs which is achieved through: A comprehensive understanding of how the human

body works at the molecular level. A much better grasp of the killer-effects from

consumptions of drugs including side effects and intricacies caused

Greater collaboration between the industry, academia, the regulators, governments and healthcare providers.

Page 3: Analytics in Pharmaceutical Industry

Insights….

Page 4: Analytics in Pharmaceutical Industry

Business Problem-1• It is acknowledged that the pharmaceuticals industry has enormous

expenditure in building a successful molecular composition in a time frame. R&D activity which is extensively outsourced predominantly occupies a great share of the incurred cost.

Page 5: Analytics in Pharmaceutical Industry

Analytical consultation• Bench marking of the outsourced R&D

– The R&D divisions per phase , per drug, per disease are benchmarked to indentify the best and the worst performing units resulting in the

significant reduction of the outsourcing costs.– The analytical solution provides atleast a 40 %

saving

average R&D cost per unit Average cost after bench marking

0102030405060708090

100

(in m

illio

ns)

Cost saved is 40%

Page 6: Analytics in Pharmaceutical Industry

Cost model

average Estimated cost for a molecule composition 1 Billion $

average Number of phases 10average number of R&D units per phase 10

average cost /R&D unit 10 M$expected savings if the 4 least performing units are stopped funding 40 M$

Estimated cost for benchmarking 0.3 M$ Projected price for providing this analysis 4 M$

Page 7: Analytics in Pharmaceutical Industry

Technical analysis For Benchmark

• DATA TYPE: Disease(cat), Drug(cat), Costs Incurred(neu),Cost, Time Period(neu),

Number of Failures before successful experiment(neu), Team Size(neu), Successful/Failure Experiment (cat), R&D Firm(cat), R&D Firm Demographics(cat), R&D Firm Size(neu), etc

• DATA VOLUME: 20 to 40 input and output parameters

• IMPLEMENTATION: Quantify the level/positioning of each R&D Firm and identify top most firms for outsourcing.

• PROBLEM CLASS: Linear Optimization

• TECHNIQUE: DEA

Page 8: Analytics in Pharmaceutical Industry

Business Problem-2 The formula of the created molecular composition many a time goes to

trash as the usage results many a side effect apart the suffering of patent uniqueness.

Page 9: Analytics in Pharmaceutical Industry

Pharma Killer effects and patent tool (PAT -- Pharma analytic tool)

• The software tool that we would be providing would explain the pharma scientist the possible side effects and its intensity for a molecular composition.

• It also validates the formula for its uniqueness by checking with the patent database

• Maintenance and service is entertained for this tool.

• Based on the data generation, the tool would upgrade itself and provide the updated results.

Page 10: Analytics in Pharmaceutical Industry

Cost model for PAT

Domain understanding 1 month

Collecting and processing of the data 3 months

Analysis and training 3 months

Testing 2 months

Integration 2 months

Design 1 months

Cost per hour 80 $Cost of the tool PAT 0.6 M $

Support per hour 60 $

Page 11: Analytics in Pharmaceutical Industry

Technical analysis for PAT• DATA TYPE: Disease(cat), Drug(cat), Molecule Composition(cat),Costs Incurred(neu), Time

Period(neu), Number of Failures before successful experiment(neu), Side effects and/or Intricacies if any (cat)

• DATA VOLUME: One Record for each type of molecule composition. Patent database.

• IMPLEMENTATION: Given the molecule composition of a drug, to classify whether Side effects and/or Intricacies is caused or not. And if caused then which out of given Side effects and/or Intricacies categories. Patent search,

• ERROR MEASURE: RECALL

• PROBLEM CLASS: CLASSIFICATION

• TECHNIQUE: DECISION TREE,NAÏVE BAYES, RANDOM FOREST, Page ranking, K-NN using HADOOP

Page 12: Analytics in Pharmaceutical Industry

PAT Framework

Page 13: Analytics in Pharmaceutical Industry

No

of R

ejec

ted

expe

rimen

ts a

t app

rova

l boa

rd

Page 14: Analytics in Pharmaceutical Industry

Killer experiments

Tim

e co

nsum

ed

Histo

ricall

y obs

erve

d

Projected

The tool saves the 40 % time wastage in killer experiments and patent findings.

40%

Page 15: Analytics in Pharmaceutical Industry

For Individuals: +91-9177585755 or 040-65743991

For Corporates: +91-9618483483

Web: http://www.insofe.edu.in

Facebook: http://www.facebook.com/insofe

Twitter: https://twitter.com/INSOFEedu

YouTube: http://www.youtube.com/InsofeVideos

SlideShare: http://www.slideshare.net/INSOFE

LinkedIn: http://www.linkedin.com/company/international-school-of-engineering

This presentation may contain references to findings of various reports available in the public domain. INSOFE makes no representation as to their accuracy or that the

organization subscribes to those findings.

The best place for students to learn Applied Engineering http://www.insofe.edu.in

International School of Engineering

2-56/2/19, Khanamet, Madhapur, Hyderabad - 500 081